# Heterologous Boost Immunization with an Aerosolised Ad5-nCoV After Two-dose Priming with an Inactivated SARS-CoV-2 Vaccine

> **NCT05204589** · PHASE3 · COMPLETED · sponsor: **Jiangsu Province Centers for Disease Control and Prevention** · enrollment: 10285 (actual)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** Aerosolized Ad5-nCoV
- **BIOLOGICAL:** Inactivated SARS-CoV-2 vaccine

## Key facts

- **NCT ID:** NCT05204589
- **Lead sponsor:** Jiangsu Province Centers for Disease Control and Prevention
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-22
- **Primary completion:** 2022-04-01
- **Final completion:** 2022-10-27
- **Target enrollment:** 10285 (ACTUAL)
- **Last updated:** 2025-02-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05204589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05204589, "Heterologous Boost Immunization with an Aerosolised Ad5-nCoV After Two-dose Priming with an Inactivated SARS-CoV-2 Vaccine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05204589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*